SEC Form 4 · accession 0001193125-26-257902
Kura Oncology, Inc. · KURA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Vasconcelles
Director
Period of report
Jun 4, 2026
Accepted (ET)
Jun 4, 2026 · 6:30 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001422143
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to purchase common stockF1 | $8.77 | Jun 4, 2026 | A | 35,000 | A | — | Jun 3, 2036 | Common Stock | 35,000 | 35,000 | D |
Explanation of responses
- F1This option vests in full on the one year anniversary of the date of grant.